Hydroxyethyl starch 6% 130/0.42 in acetate-buffered Ringer's solution as a part of a balanced-volume resuscitation in abdominal surgery;Hydroxyethylstärke 6% 130/0,42 in Ringerazetat als komponente eines balancierten volumenersatzes in der abdominalchirurgie

Anasthesiologie und Intensivmedizin

Volumn 49, Issue 1, 2008, Pages 7-18

  Kulla, Martin ^a   Weidhase, R ^b   Lampl, L ^a  

^a BUNDESWEHRKRANKENHAUS ULM   (Germany)

^b Serumwerk Bernburg AG   (Germany)

Author keywords

Acid base status; Hydroxyethyl starch; Ringer's acetate solution; Surgery; Volume resuscitation

Indexed keywords

ELECTROLYTE; HETASTARCH; RINGER ACETATE;

ABDOMINAL SURGERY; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD GAS ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIURESIS; ELECTROLYTE BALANCE; GOOD CLINICAL PRACTICE; HEMODYNAMIC PARAMETERS; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; RESUSCITATION; STATISTICAL SIGNIFICANCE;

EID: 38849116547     PISSN: 01705334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Webb AR. Crystalloid or colloid for resuscitation. Are we any the wiser? Critical Care 1999;3:R25-R28.
2. Zander R, Adams HA, Boldt J, Hiesmayr MJ, Meier-Hellmann A, Spahn DR, et al. Forderungen und Erwartungen an einen optimalen Volumenersatz. Anästhesiol Intensivmed Notfallmed Schmerzther 2005;40:701-719.
3. Zausig YA, Weigand MA, Graf BM. Perioperatives Flüssigkeitsmanagement: Eine Analyse der aktuellen Studienlage. Anaesthesist 2006;55:371-390.
4. Deane SA, Gaudry PL, Woods P, Cass D, Hollands MJ, Cook RJ, et al. The management of injuries - a review of deaths in hospital. Aust N Z J Surg 1998;58:463-469.
5. Mythen MG, Webb AR. Intra-operative gut mucosal hypoperfusion is associated with increased post-operative complications and cost. Intensive Care Med 1994;20:99-104.
6. Hinder F, Stubbe HD, Van Aken H, Baba HA, Jahn UR, Brodner G, et al. Early multiple organ failure after recurrent endotoxemia in the presence of vasoconstrictor-masked hypovolemia. Crit Care Med 2003;31:903-909.
7. Wiedermann CJ. Hydroxyethyl starch - can the safety problems be ignored? Wien Klin Wochenschr 2004;116:583-594.
8. Hoffmann JN, Vollmar B, Laschke MW, Inthorn D, Schildberg FW, Menger MD. Hydroxyethyl starch (130 kD), but not crystalloid volume support, improves microcirculation during normotensive endotoxemia. Anesthesiology 2002;97:460-470.
9. Norberg Å, Brauer KI, Prough DS, Gabrielsson J, Hahn RG, Uchida T, et al. Volume turnover kinetics of fluid shifts after hemorrhage, fluid infusion, and the combination of hemorrhage and fluid infusion in sheep. Anesthesiology 2005;102:985-994.
10. Asskali F, Förster H. Zur Kumulation unterschiedlich substituierter Hydroxyethylstärke (HES) nach repetitiver Infusion bei gesunden Versuchspersonen. Anästhesiol Intensivmed Notfallmed Schmerzther 1999;34:537-541.
11. Boldt J. New light on intravascular volume replacement regimens: what did we learn from the past three years? Anesth Analg 2003;97:1595-1604.
12. Boldt J, Schöllhorn T, Münchbach J, Pabsdorf M. A total balanced volume replacement strategy using a new balanced hydroxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery. Eur J Anaesthesiol 2006:1-9.
13. Gan TJ, Bennett-Guerrero E, Phillips-Bute B, Wakeling H, Moskowitz DM, Olufolabi Y, et al. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group. Anesth Analg 1999;88:992-998.
14. Kellum JA. Saline-induced hyperchloremic metabolic acidosis. Crit Care Med 2002;30:259-261.
15. Waters JH, Bernstein CA. Dilutional acidosis following hetastarch or albumin in healthy volunteers. Anesthesiology 2000;93:1184-1187.
16. Wilkes NJ, Woolf RL, Powanda MC, Gan TJ, Machin SJ, Webb A, et al. Hydroxyethyl starch in balanced electrolyte solution (Hextend) - pharmacokinetic and pharmacodynamic profiles in healthy volunteers. Anesth Analg 2002;94:538-544.
17. Brill SA, Stewart TR, Brundage SI, Schreiber MA. Base deficit does not predict mortality when secondary to hyperchloremic acidosis. Shock 2002;17:459-462.
18. Prough DS, White RT. Acidosis associated with perioperative saline administration: dilution or delusion? Anesthesiology 2000;93:1167-1169.
19. Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest 1983;71:726-735.
20. Zander R. Base Excess und Laktatkonzentration von Infusionslösungen und Blutprodukten. Anästhesiol Intensivmed Notfallmed Schmerzther 2002;37:359-363.
21. Sander O, Reinhart K, Meier-Hellmann A. Equivalence of hydroxyethyl starch HES 130/0.4 and HES 200/0.5 for perioperative volume replacement in major gynaecological surgery. Acta Anaesthesiol Scand 2003;47:1151-1158.
22. Brandstrup B, Tønnesen H, Beier-Holgersen R, Hjortsø E, Ording H, Lindorff-Larsen K, et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg 2003;238:641-648.
23. Brock H, Gabriel C, Bibl D, Necek S. Monitoring intravascular volumes for postoperative volume therapy. Eur J Anaesthesiol 2002;19:288-294.
24. Wiesenack C, Prasser C, Keyl C, Rodig G. Assessment of intrathoracic blood volume as an indicator of cardiac preload: single transpulmonary thermodilution technique versus assessment of pressure preload parameters derived from a pulmonary artery catheter. J Cardiothorac Vasc Anesth 2001;15:584-588.
25. Rehm M, Conzen PF, Peter K, Finsterer U. Das Stewart-Modell - "Moderner" Ansatz zur Interpretation des Säure-Basen-Haushalts. Anaesthesist 2004;53:347-357.
26. Meng ZH, Wolberg AS, Monroe DM, Hoffman M. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 2003;55:886-891.
27. Lefering R, Rixen D. Auszug aus dem Traumaregister der DGU (Deutsche Gesellschaft für Unfallchirurgie) I. Köln, Institut für Forschung in der Operativen Medizin, Fakultät für Medizin, Private Universität Witten/Herdecke; 2006.
28. Gallandat Huet RC, Siemons AW, Baus D, van Rooyen-Butijn WT, Haagenaars JA, van Oeveren W, et al. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth 2000;47:1207- 1215.
29. Boldt J, Haisch G, Suttner S, Kumle B, Schellhaass A. Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation. Br J Anaesth 2002;89:722-728.
30. Chen G, Yan M, Lu QH, Gong M. Effects of two different hydroxyethyl starch solutions (HES200/0.5 vs. HES130/0.4) on the expression of platelet membrane glycoprotein. Acta Anaesthesiol Scand 2006;50:1089-1094.
31. Franz A, Bräunlich P, Gamsjäger T, Felfernig M, Gustorff B, Kozek-Langenecker SA. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001;92:1402-1407.
32. Haisch G, Boldt J, Krebs C, Kumle B, Suttner S, Schulz A. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg 2001;92:565-571.
33. Haisch G, Boldt J, Krebs C, Suttner S, Lehmann A, Isgro F. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth 2001;15:316-321.
34. Knutson JE, Deering JA, Hall FW, Nuttall GA, Schroeder DR, White RD, et al. Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesth Analg 2000;90:801-807.
35. Madjdpour C, Dettori N, Frascarolo P, Burki M, Boll M, Fisch A, et al. Molecular weight of hydroxyethyl starch: is there an effect on blood coagulation and pharmacokinetics? Br J Anaesth 2005;94:569-576.
36. Martin G, Bennett-Guerrero E, Wakeling H, Mythen MG, El-Moalem H, Robertson K, et al. A prospective, randomized comparison of thromboelastographic coagulation profile in patients receiving lactated Ringer's solution, 6% hetastarch in a balanced-saline vehicle, or 6% hetastarch in saline during major surgery. J Cardiothorac Vasc Anesth 2002;16:441-446.
37. Roche AM, James MF, Bennett-Guerrero E, Mythen MG. A head-to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystalloid and colloid intravenous fluids. Anesth Analg 2006;102:1274-1279.
38. Niemi TT, Kuitunen AH. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand 2005;49:373-378.
39. Petroianu GA, Liu J, Maleck WH, Mattinger C, Bergler WF. The effect of In vitro hemodilution with gelatin, dextran, hydroxyethyl starch, or Ringer's solution on Thrombelastograph. Anesth Analg 2000;90:795-800.
40. Davidson IJ. Renal impact of fluid management with colloids: a comparative review. Eur J Anaesthesiol 2006;23:721-738.
41. Dehne MG, Mühling J, Sablotzki A, Papke G, Kuntzsch U, Hempelmann G. Einfluss von Hydroxyethylstärkelösung auf die Nierenfunktion bei operativen Intensivpatienten. Anästhesiol Intensivmed Notfallmed Schmerzther 1997;32:348-354.
42. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357:911-916.
43. Suttner S, Boldt J. Beeinflusst die Gabe von Hydroxyethylenstärke die Nierenfunktion? Anästhesiol Intensivmed Notfallmed Schmerzther 2004;39:71-77.
44. Christidis C, Mal F, Ramos J, Senejoux A, Callard P, Navarro R, Trinchet JC, et al. Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions. J Hepatol 2001;35:726-732.
45. Leuschner J, Opitz J, Winkler A, Scharpf R, Bepperling F. Tissue storage of 14C-labelled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intravenous administration to rats. Drugs R D 2003;4:331-338.
46. Kellum JA. Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared with saline. Crit Care Med 2002;30:300-305.
47. Bork K. Pruritus precipitated by hydroxyethyl starch: a review. Br J Dermatol 2005;152:3-12.